483
Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.FDA 483 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. in Changzhou, China, an API manufacturer. The inspection revealed significant deficiencies in control record management, specifically regarding logbook reconciliation and the lack of hard-bounded, numbered pages. Additionally, the firm's quality assurance unit failed to conduct comprehensive reviews of electronic data and audit trails for analytical results.
- Product Type
- Drugs
Open in Dashboard
ID · 88731eb4-5ab6-4b2a-b83c-bc408946c100